PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23877009-9	2013	Exposure of PX-866 treated cells to sorafenib reduced p62 and LAMP2 levels, decreased the ratio of LC3 to LC3II, and reduced LC3-GFP vesicle levels.	Sorafenib	36-45	microtubule associated protein 1 light chain 3 alpha	Homo sapiens	99-102	
23877009-9	2013	Exposure of PX-866 treated cells to sorafenib reduced p62 and LAMP2 levels, decreased the ratio of LC3 to LC3II, and reduced LC3-GFP vesicle levels.	Sorafenib	36-45	microtubule associated protein 1 light chain 3 alpha	Homo sapiens	106-109